Stroke & Society : Dr Vijay Sardana

STROKE & SOCIETY Vijay Sardana MD;DM Professor & Head Deptt of Neurology Medical college, KOTA

Stroke Definition ,[object Object]

Stroke ,[object Object],[object Object]

STROKE Epidemiology ,[object Object],[object Object],[object Object],[object Object],[object Object]

Stroke : India ,[object Object],[object Object],[object Object],[object Object]

Stroke India Annual incidence ,[object Object],[object Object],[object Object],[object Object]

Stroke Prevalence ,[object Object],[object Object],[object Object]

WHO – Global Stroke Mortality Projections 2003 to 2030 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Stroke: India ,[object Object],[object Object],[object Object]

Raised Stroke burden in India ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Stroke & community ,[object Object],[object Object]

Stroke care in community ,[object Object],[object Object]

STROKE MORTALITY IN INDIA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Stroke outcome ,[object Object],[object Object],[object Object]

STROKE SPECIFIC TO INDIA ,[object Object],[object Object],[object Object],[object Object]

Stroke- what needs to be done ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Stroke care in community ,[object Object],[object Object],[object Object],[object Object]

Stroke care in Community issues ,[object Object],[object Object],[object Object],[object Object]

Ischemic st roke Time window in Brain ,[object Object],[object Object],[object Object],[object Object],[object Object]

Ischaemic Stroke Brain Oedema ,[object Object],[object Object],[object Object]

Diagnostic evaluation Stroke mimics Hypoglycemia Hyperglycemia Hepatic encephalopathy Seizures Hemiplegic migraine SDH Brain abcess Hypertensive encephalopathy MS Hysterical Stroke chameleons Acute confusional states Seizures with acute strokes Sensory symptoms Movement disorders ,[object Object]

Ischaemic Stroke ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Ischaemic Stroke ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Ischaemic Stroke ,[object Object],[object Object],[object Object]

Time of onset of isch stroke ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Ischaemic Stroke Focal Cerebral Aetiology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Ischaemic Stroke ,[object Object],[object Object],[object Object],[object Object],[object Object]

Stroke - Diagnosis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Cardioembolic Stroke Criteria ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Stroke early CT Signs ,[object Object],[object Object],[object Object]

Management of Ischaemic Stroke ,[object Object],[object Object],[object Object]

Stroke Management - Variations ,[object Object],[object Object],[object Object],[object Object]

RAPID CLINICAL EVALUATION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],NIHSS <10: 60-70% Favorable outcome after 1 yr ;3% chance of ICH NIHSS >20: 4-16% have favorable outcome; 17% chance of ICH

EMERGENCY ROOM ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

NINDS – Recommended stroke evaluation target for Thrombolysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Ischaemic Stroke ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Stroke – what needs to be done ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Stroke units ,[object Object],[object Object],[object Object],[object Object],[object Object]

Stroke unit : 100 ,[object Object],[object Object],[object Object]

Stroke service in developing countries Brazil Iran China Pakistan India Neurologist 5000 420 20,000 60 1500 Neurology deptt. 90 24 1500 15 40 Stroke units 35 20 150 5 100 Stroke Prevalence /1,00,000 128 43 400 48 545

Stroke unit- Aims ,[object Object],[object Object],[object Object]

Stroke unit ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Kota Med college Stroke unit : policies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Stroke Therapy - Breakthrough ,[object Object]

Thrombolysis ,[object Object],[object Object]

Ischaemic Stroke Thrombolytic Therapy ,[object Object],[object Object]

Ischaemic Stroke Thrombolytic agents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Eligibility Criteria for iv TPA ,[object Object],[object Object],[object Object],[object Object]

Exclusion criteria ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Thrombolysis - advantage with Kota ,[object Object],[object Object],[object Object],[object Object]

TPA cost in developing country ,[object Object],[object Object],[object Object],[object Object],[object Object]

Acute Ischaemic Stroke Medical Therapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Treatment of Acute Ischaemic Stroke ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Ischaemic Stroke Antiplatelet Agents ,[object Object],[object Object],[object Object],[object Object],[object Object]

Ischaemic Stroke - Clopidogrel ,[object Object],[object Object],[object Object],[object Object],[object Object]

Ischaemic Stroke Anticoagulation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Management of Acute Ischaemic Stroke ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Ischaemic Stroke Prevention After first Stroke ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Ischaemic Stroke Prevention Atrial Fibrillation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

We have a dream ,[object Object],[object Object],[object Object],[object Object]

We have a dream ,[object Object],[object Object],[object Object]

Stroke & Society : Dr Vijay Sardana

Recomendados

Recomendados

Mais conteúdo relacionado

Mais procurados

Mais procurados (20)

Semelhante a Stroke & Society : Dr Vijay Sardana

Semelhante a Stroke & Society : Dr Vijay Sardana (20)

Mais de Vijay Sardana

Mais de Vijay Sardana (17)

Último

Último (20)

Stroke & Society : Dr Vijay Sardana

Notas do Editor